Positive phase 3 results from two clinical trials suggests that Sol-Gel’s novel 5% microencapsulated benzoyl peroxide cream may offer quick, effective relief for patients with papulopustular rosacea.
Sun Pharma introduces a lower dose isotretinoin capsule in the U.S. for the treatment of severe recalcitrant nodular acne.
How does an aesthetic practice decide whether to invest in body toning technologies? We asked several aesthetic physicians to share what they’ve learned about what differentiates the technologies and more.
Cosmetic Surgery Forum (CSF) Founder Joel Schlessinger, M.D., Omaha, Neb., sits down with Dermatology Times to give an inside glimpse into the meeting's 11th year.
Dr. Diane Berson spoke with Dermatology Times at ASDS 2019 about her presentation revolving around hormones' effect on hair changes in postmenopausal women.
It’s an exciting time for atopic dermatitis patients as many new treatment options are on the market and in the pipeline. But treatment doesn’t yet offer a cure and many patients continue to suffer with symptoms, including itch, psychosocial and quality-of-life issues, according to a recent paper.
The link between menopause and aging is one that many patients aren’t aware is affecting them. Speaking with Dermatology Times at ASDS 2019, Dr. Diane Berson highlighted the topic in her presentation on hormones and postmenopausal women.
Abnormalities in epidermal barrier integrity, affecting factors such as epidermal calcium gradients, filaggrin, cornified envelopes, desquamation of corneodesmosomes and skin lipids, may also influence epidermal barrier dysfunction, according to a recent review.
Read the highlights from our February 2020 issue in the slideshow below.
A recent chart review found that eczematous eruptions occurred in 5.8% of patients using interleukin (IL)-17 inhibitors for psoriasis. Its authors believe that additional research could help identify which patients may be most at risk.